{"id":309462,"date":"2019-12-11T20:50:53","date_gmt":"2019-12-12T04:50:53","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/12\/healthcare-roundup-assembly-biosciences-readies-equity-offering-gilead-files-u-s-application\/"},"modified":"2019-12-11T20:51:36","modified_gmt":"2019-12-12T04:51:36","slug":"%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e7%b2%be-assembly-biosciences-%e6%ba%96%e5%82%99%e7%99%bc%e8%a1%8c%e8%82%a1%e7%a5%a8%e5%90%89%e5%88%a9%e5%be%b7%e6%8f%90%e4%ba%a4%e4%ba%86%e7%be%8e%e5%9c%8b","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2019\/12\/%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e7%b2%be-assembly-biosciences-%e6%ba%96%e5%82%99%e7%99%bc%e8%a1%8c%e8%82%a1%e7%a5%a8%e5%90%89%e5%88%a9%e5%be%b7%e6%8f%90%e4%ba%a4%e4%ba%86%e7%be%8e%e5%9c%8b\/","title":{"rendered":"\u91ab\u7642\u4fdd\u5065\u7cbe\u9078\u2014\u2014Assembly Biosciences\u6e96\u5099\u767c\u884c\u80a1\u7968\uff0c\u5409\u5229\u5fb7\u63d0\u4ea4\u4e86\u7f8e\u570b\u7533\u8acb"},"content":{"rendered":"<h2>Assembly Biosciences\u6e96\u5099\u767c\u884c\u80a1\u7968<\/h2>\n<p><a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=ASMB\">Assembly Biosciences\uff08NASDAQ\uff1aASMB\uff09<\/a>\u516c\u958b\u767c\u884c\u666e\u901a\u80a1\u3002\u50f9\u683c\u3001\u6578\u91cf\u548c\u689d\u6b3e\u5c1a\u672a\u516c\u4f48\u3002\u76e4\u5f8c\u80a1\u50f9\u4e0b\u8dcc4%\u3002<\/p>\n<p>\u5409\u5229\u5fb7\u63d0\u4ea4CAR T\u6cbb\u7642\u5957\u7d30\u80de\u6dcb\u5df4\u7624\u7684\u7533\u8acb<\/p>\n<p><a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=GILD\">\u5409\u5229\u5fb7\u79d1\u5b78\uff08\u7d0d\u65af\u9054\u514b\u80a1\u7968\u4ee3\u78bc\uff1aGILD\uff09<\/a>\u7684\u5b50\u516c\u53f8Kite\u5df2\u5411FDA\u63d0\u4ea4\u4e86\u71df\u92b7\u7533\u8acb\uff0c\u4ee5\u5c0b\u6c42\u6279\u51c6CAR T\u7642\u6cd5KTE-X19\u7528\u65bc\u6cbb\u7642\u5fa9\u767c\/\u96e3\u6cbb\u6027\u5957\u7d30\u80de\u6dcb\u5df4\u7624\uff08\u4e00\u7a2e\u7de9\u6162\u751f\u9577\u7684NHL\uff09\u3002<\/p>\n<p>\u8a72\u516c\u53f8\u8a08\u5283\u5728\u4e0b\u500b\u5b63\u5ea6\u5728\u6b50\u6d32\u63d0\u51fa\u7533\u8acb\u3002<\/p>\n<h2>Endonovo Therapeutics\u5ba3\u4f48\u53cd\u5411\u80a1\u7968\u5206\u62c6<\/h2>\n<p><a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=ENDV\">Endonovo Therapeutics\uff08OTCQB\uff1aENDV-33.3%\uff09<\/a>\u5ba3\u4f48\u5df2\u6c7a\u5b9a\u5c0d\u516c\u53f8\u5df2\u767c\u884c\u666e\u901a\u80a1\u9032\u884c\u53cd\u5411\u62c6\u5206\u3002\u9019\u5c07\u4f7f\u516c\u53f8\u666e\u901a\u80a1\u7684\u6d41\u901a\u80a1\u6578\u91cf\u6e1b\u5c11\u5230\u7d04100,530\u80a1\u3002<\/p>\n<h2>\u8afe\u83ef\u8207Forendo Pharma\u5408\u4f5c\u6cbb\u7642\u809d\u81df\u75be\u75c5<\/h2>\n<p>\u8afe\u83ef\uff08-0.1%\uff09\u8207\u82ac\u862dForendo Pharma\u9054\u6210\u4e00\u9805\u5354\u8b70\uff0c\u65e8\u5728\u767c\u73fe\u7528\u65bc\u6cbb\u7642\u6162\u6027\u809d\u75c5\u7684\u65b0\u85e5\u3002<\/p>\n<p>\u6839\u64da\u4ea4\u6613\u689d\u6b3e\uff0cForendo\u5c07\u7372\u5f97\u9810\u4ed8\u6b3e\u3001\u7814\u7a76\u7d93\u8cbb\u3001\u91cc\u7a0b\u7891\u548c\u6de8\u92b7\u552e\u984d\u7684\u5206\u5c64\u7279\u8a31\u6b0a\u4f7f\u7528\u8cbb\uff0c\u4ee5\u53ca\u8afe\u83ef\u7684\u80a1\u6b0a\u3002\u7814\u7a76\u5408\u4f5c\u7d50\u675f\u5f8c\uff0c\u8afe\u83ef\u5c07\u63a5\u7ba1\u6240\u6709\u958b\u767c\u3001\u88fd\u9020\u548c\u5546\u696d\u5316\u6d3b\u52d5\u3002<\/p>\n<p>Forendo Pharma\u7684\u6838\u5fc3\u5c08\u9577\u662f\u4e00\u500b\u540d\u70baHSD17B\uff0817-\u03b2-\u7fa5\u57fa\u985e\u56fa\u9187\u812b\u6c2b\u9176\uff09\u7684\u9176\u5bb6\u65cf\uff0c\u8a72\u9176\u5728\u8abf\u7bc0\u6fc0\u7d20\u4f5c\u7528\u4e2d\u8d77\u95dc\u9375\u4f5c\u7528\u3002\u5b83\u7684\u4e3b\u8981\u9805\u76ee\u662f\u7528\u65bc\u5b50\u5bae\u5167\u819c\u7570\u4f4d\u75c7\u76841b\u671fHSD17B\u6291\u5236\u5291FOR-6219\u3002<\/p>\n<h2>\u555f\u52d5\u4e73\u817a\u764c\u6e2c\u8a66\uff0cGenetic Tech\u4e0a\u6f3222%<\/h2>\n<p><a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=GENE\">Genetic Technologies Limited\uff08GENE + 21.6%\uff09<\/a>\u7684\u6210\u4ea4\u91cf\u589e\u9577\u4e86\u8fd15\u500d\uff0c\u9019\u662f\u7531\u65bc\u8a72\u516c\u53f8\u4f5c\u51fa\u4e86\u7b2c\u4e09\u4ee3\u4e73\u817a\u764c\u6e2c\u8a66\u5728\u4e0b\u500b\u5b63\u5ea6\u958b\u59cb\u92b7\u552e\u7684\u516c\u544a\u3002<\/p>\n<p>\u8a72\u516c\u53f8\u7684\u76ee\u6a19\u662f\u5efa\u7acb12\u500b\u81e8\u5e8a\u7ad9\u9ede\uff0c\u4ee5\u5c55\u793a\u5be6\u7528\u6027\u3001\u7528\u6236\u9ad4\u9a57\u3001\u5831\u92b7\u548c\u5206\u914d\u3002\u9019\u9805\u88ab\u7a31\u70ba\u201c\u4e73\u817a\u764c\u57fa\u56e0\u985e\u578b\u201d\u7684\u6e2c\u8a66\u901a\u904e\u7d50\u5408DNA\u548c\u4e73\u817aX\u7dda\u651d\u5f71\u6578\u64da\u4f86\u9810\u6e2c\u75be\u75c5\u98a8\u96aa\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Assembly Biosciences readies equity offering; shares down 4% after hours. Gilead Sciences (NASDAQ:GILD) unit Kite has submitted a marketing application to the FDA seeking approval for CAR T therapy KTE-X19 for the treatment of adults with relapsed\/refractory mantle cell lymphoma, a type of slow-growing NHL.<\/p>\n","protected":false},"author":9,"featured_media":309444,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[927,563,644,564],"class_list":["post-309462","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-927","tag--zh-hant","tag-644","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant","exchange-nyse-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/309462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=309462"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/309462\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/309444"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=309462"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=309462"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=309462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}